Bill of Health
JULY 15, 2022
Government Patent Use to Promote Public Health in the United States: Overcoming Nonpatent Exclusivities. Am J Public Health. Post-Marketing Requirements for Cancer Drugs Approved by the European Medicines Agency, 2004-2014. What to Know About the Alzheimer Drug Aducanumab (Aduhelm). JAMA Intern Med. 2022 Jun 6.
Bill of Health
JANUARY 3, 2023
Back in 2004, Justice Thomas was one of three dissenters in Raich. Indeed, the Court now features more Commerce Clause conservatives than when Marino et al.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Health Populi
JUNE 17, 2021
healthcare system since Dr. Charles Safran testified with that statement to Congress way back in 2004 …an era where bipartisanship for health IT was a real thing. healthcare system — overused, over-stressed, under-paid, detailed n How Health Systems Can Care for Caregivers , published in the NEJM Catalyst July 2021 issue.
HIPAA Journal
MAY 23, 2022
Department of Health and Human Services’ Health Sector Cybersecurity Coordination Center (HC3) has issued a threat brief providing information on the cyber organizations of the Russian Intelligence Services which pose a threat to organizations in the United States, including the healthcare and public health (HPH) sector.
Bill of Health
AUGUST 29, 2022
is not a state, there is no foundation for public education. 2004) (“[T] the fundamental right to an opportunity for an education does not guarantee that a student cannot temporarily forfeit educational services through his own conduct. However, because Washington, D.C., at 795–96 (citing In re RM , 102 P.3d 3d 868, 874 (Wyo.
Bill of Health
AUGUST 4, 2023
After all, following 9/11 President Bush (and VP Cheney and Secretary Rumsfeld) were extremely concerned about bioterrorism, resulting in Bush’s presidential directive of 2004 (reauthorized in 2007 ) to improve the country’s biodefense plans and weapons. Or perhaps the site decision itself was an afterthought.
SQA
DECEMBER 16, 2022
It will also facilitate cross-border circulation of these critical health therapies as well as cross-border cooperation between public health authorities. This proposal builds upon the existing legal framework, which came into force in 2002 for blood and 2004 for tissues and cells.
Expert insights. Personalized for you.
208 
Let's personalize your content